"10.1371_journal.pone.0142534","plos one","2015-11-11T00:00:00Z","Réjean Thomas; Chrissi Galanakis; Sylvie Vézina; Danièle Longpré; Michel Boissonnault; Emmanuelle Huchet; Louise Charest; Daniel Murphy; Benoît Trottier; Nimâ Machouf","Clinique médicale lActuel, Montreal, Quebec, Canada","Conceived and designed the experiments: NM CG. Performed the experiments: RT BT SV EH DL LC MB. Analyzed the data: CG NM. Wrote the paper: RT BT CG NM. Manuscript review and clinical input: SV DL MB EH LC DM.","RT has been an advisory board member for Abbvie, Bristol-Myers Squibb, Gilead, Janssen, Merck and ViiV Healthcare. SV has been a guest speaker for Gilead. DL has been an advisory board member for Abbvie, Merck, Gilead, ViiV Healthcare and Janssen and has been invited to events sponsored by Gilead, Merck and Bristol-Myers Squibb. LC has been an advisory board member for Abbott, Bristol-Myers Squibb, Gilead, Janssen, Merck and ViiV Healthcare. DM has been an advisory board member Bristol-Myers Squibb, Gilead, Janssen, Merck and a consultant for the latter in addition to ViiV Healthcare. DM has also been a speaker at events sponsored Bristol-Myers Squibb, Gilead, and Janssen. BT received honoraria as a speaker or consultant from Abbvie, BMS, Gilead, Janssen, Merck, ViiV Healthcare. NM has been a speaker at events sponsored by Merck and Gilead. MB and EH have been advisory board members for Abbvie, Bristol-Myers Squibb, Gilead, Janssen, Merck and ViiV Healthcare. CG has no conflicts of interest to declare. This does not alter the authors adherence to PLOS ONE policies on sharing data and materials.","2015","11","Réjean Thomas","RT",10,TRUE,2,7,2,4,TRUE,FALSE,FALSE,0,NA,FALSE
